NLRP3 and coronary artery disorder: A study conducted by Li et al. demonstrated that patients with diabetic STEMI exhibited higher expression levels of pyruvate kinase M2 (PKM2), NLRP3, IL-1β, and IL-18 compared to patients with non-diabetic STEMI and stable coronary heart disease [56].